The biopharmaceutical industry stands at a critical juncture where the integration of artificial intelligence (AI) into contract development and manufacturing organizations (CDMOs) is no longer a distant vision but a pressing reality. With the global biopharma market facing mounting pressure to
Spinal Muscular Atrophy (SMA), a rare genetic disorder that causes progressive muscle weakness and significant life challenges, has long been a focus of medical research seeking transformative solutions for affected individuals across all ages. A pivotal moment in this journey arrived on November
What lies at the heart of life’s intricate design, shaping everything from a single cell to the complex tissues of the human body? The answer may surprise many: it’s not just the cells themselves, but the unseen network surrounding them, known as the extracellular matrix (ECM). This dynamic web of
Could a tiny, often overlooked component of the immune system hold the answer to saving the pork industry from a billion-dollar scourge? Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) devastates pig herds worldwide, slashing productivity and straining farm economies with staggering
Imagine a world where damaged tissues and organs can be repaired using a resource readily available in the human body, transforming the landscape of medical treatment as we know it today. This vision is inching closer to reality with the remarkable advancements in fat stem cell research, a field
I'm thrilled to sit down with Ivan Kairatov, a seasoned biopharma expert with a wealth of experience in research and development. With a sharp focus on technology and innovation, Ivan has been at the forefront of advancing biologics formulation, particularly in tackling the complex challenges of
